Your browser doesn't support javascript.
loading
Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.
Tomioka, Nobumoto; Hatanaka, Kanako C; Okuyama, Dai; Watanabe, Ken-Ichi; Yamamoto, Mitsugu; Maeda, Hideki; Tachikawa, Hanae; Kuwahara, Sayuri; Shimizu, Ai; Suzuki, Hiroaki; Hatanaka, Yutaka; Takahashi, Masato.
Afiliación
  • Tomioka N; Department of Breast Surgery, National Hospital Organization (NHO) Hokkaido Cancer Center, 4-2 Kikusui, Shiroishi-ku, Sapporo, 003-0804, Japan. nmhtomsfhcc@yahoo.co.jp.
  • Hatanaka KC; Clinical Research and Medical Innovation Center of Development of Advanced Diagnostics, Hokkaido University Hospital, Sapporo, Japan.
  • Okuyama D; Department of Clinical Pathology, National Hospital Organization (NHO) Hokkaido Cancer Center, Sapporo, Japan.
  • Watanabe KI; Department of Breast Surgery, National Hospital Organization (NHO) Hokkaido Cancer Center, 4-2 Kikusui, Shiroishi-ku, Sapporo, 003-0804, Japan.
  • Yamamoto M; Department of Breast Surgery, National Hospital Organization (NHO) Hokkaido Cancer Center, 4-2 Kikusui, Shiroishi-ku, Sapporo, 003-0804, Japan.
  • Maeda H; Department of Breast Surgery, National Hospital Organization (NHO) Hokkaido Cancer Center, 4-2 Kikusui, Shiroishi-ku, Sapporo, 003-0804, Japan.
  • Tachikawa H; Department of Breast Surgery, National Hospital Organization (NHO) Hokkaido Cancer Center, 4-2 Kikusui, Shiroishi-ku, Sapporo, 003-0804, Japan.
  • Kuwahara S; Department of Breast Surgery, National Hospital Organization (NHO) Hokkaido Cancer Center, 4-2 Kikusui, Shiroishi-ku, Sapporo, 003-0804, Japan.
  • Shimizu A; Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.
  • Suzuki H; Department of Clinical Pathology, National Hospital Organization (NHO) Hokkaido Cancer Center, Sapporo, Japan.
  • Hatanaka Y; Clinical Research and Medical Innovation Center of Development of Advanced Diagnostics, Hokkaido University Hospital, Sapporo, Japan.
  • Takahashi M; Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Sapporo, Japan.
Breast Cancer ; 30(4): 689-690, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37103743
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón